Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blinded, Prospective, Randomized, Stratified, Placebo-controlled, Multi-center Study of Photodynamic Therapy With VisonacTM Cream in Patients With Moderate to Severe Acne Vulgaris.

NCT00933543 is registered in ClinicalTrials.gov with Photocure as lead sponsor.

NCT NCT00933543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00933543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blinded, Prospective, Randomized, Stratified, Placebo-controlled, Multi-center Study of Photodynamic Therapy With VisonacTM Cream in Patients With Moderate to Severe Acne Vulgaris.
Lead sponsor
Photocure
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2009
Completion date
March 31, 2010
Enrollment
107 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris